Hepatic MCPIP1 protein levels are reduced in NAFLD patients and are predominantly expressed in cholangiocytes and liver endothelium.

Natalia Pydyn Justyna Kadluczka Piotr Major Tomasz Hutsch Kinga Belamri Piotr Malczak Dorota Radkowiak Andrzej Budzyński Katarzyna Miekus Jolanta Jura Jerzy Kotlinowski

Published in: Hepatology communications (2023)

We have demonstrated that MCPIP1 protein levels are reduced in NAFLD patients, but further research is needed to investigate the specific role of MCPIP1 in NAFL initiation and the transition to NASH.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
patient reported outcomes
nitric oxide
binding protein